Company / Revenue
Elanco Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$4.7B
FY2025
5-year range
$4.4B / $4.8B
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
#20 of 155
Health Care
What the data says
Elanco's revenue of $4.7B is higher than 87% of companies in the Health Care sector (FY2025). Revenue has increased for 3 consecutive years, from $4.4B in FY2022 to $4.7B in FY2025.
Based on SEC 10-K filings.
$4.7B in FY2025 with a 5-year CAGR of +7.6%. Top quartile in the Health Care sector.
Improved from $4.4B to $4.7B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 155This company $4.7B Sector average $4.5B
▼
+5.5% above sector average
Key checks
Key Insights
- Elanco's revenue has grown for 3 consecutive years.
- 5-year CAGR of +7.6%, indicating consistent growth.
- In FY2025, revenue increased 6.2% year-over-year.
- Ranks #20 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.7B | +6.2% |
| FY2024 | $4.4B | +0.5% |
| FY2023 | $4.4B | +0.1% |
| FY2022 | $4.4B | -7.4% |
| FY2021 | $4.8B | +45.6% |
| FY2020 | $3.3B | +6.6% |
| FY2019 | $3.1B | +0.1% |
| FY2018 | $3.1B | +6.2% |
| FY2017 | $2.9B | -0.8% |
| FY2016 | $2.9B | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026